Your browser doesn't support javascript.
loading
The Beneficial Effects of Lactobacillus GG Therapy on Liver and Drinking Assessments in Patients with Moderate Alcohol-Associated Hepatitis.
Vatsalya, Vatsalya; Feng, Wenke; Kong, Maiying; Hu, Huirong; Szabo, Gyongyi; McCullough, Arthur; Dasarathy, Srinivasan; Nagy, Laura E; Radaeva, Svetlana; Barton, Bruce; Mitchell, Mack; McClain, Craig J.
Afiliação
  • Vatsalya V; Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Louisville, Louisville, Kentucky, USA.
  • Feng W; Robley Rex VA Medical Center, Louisville, Kentucky, USA.
  • Kong M; University of Louisville Alcohol Research Center, Louisville, Kentucky, USA.
  • Hu H; Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Louisville, Louisville, Kentucky, USA.
  • Szabo G; University of Louisville Alcohol Research Center, Louisville, Kentucky, USA.
  • McCullough A; Hepatobiology & Toxicology Program, University of Louisville, Louisville, Kentucky, USA.
  • Dasarathy S; Department of Pharmacology & Toxicology, University of Louisville, Louisville, Kentucky, USA.
  • Nagy LE; Department of Biostatistics and Bioinformatics, School of Public Health and Information Sciences, University of Louisville, Louisville, Kentucky, USA.
  • Radaeva S; Department of Biostatistics and Bioinformatics, School of Public Health and Information Sciences, University of Louisville, Louisville, Kentucky, USA.
  • Barton B; University of Massachusetts Medical School, Worcester, Massachusetts, USA.
  • Mitchell M; Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
  • McClain CJ; Cleveland Clinic, Cleveland, Ohio, USA.
Am J Gastroenterol ; 118(8): 1457-1460, 2023 08 01.
Article em En | MEDLINE | ID: mdl-37040544
ABSTRACT

INTRODUCTION:

We investigated the effect of daily oral Lactobacillus rhamnosus GG (LGG) in reducing liver injury/severity and drinking in patients with alcohol use disorder and moderately severe alcohol-associated hepatitis.

METHODS:

Forty-six male and female individuals with alcohol use disorder and moderate alcohol-associated hepatitis (12 ≤ model for end-stage liver disease score < 20, aged 21-67 years) received either LGG (n = 24) or placebo (n = 22). Data were collected/assessed at baseline and at 1, 3, and 6 months.

RESULTS:

LGG treatment was associated with a significant reduction in liver injury after 1 month. Six months of LGG treatment reduced heavy drinking levels to social or abstinence levels.

DISCUSSION:

LGG treatment was associated with an improvement in both liver injury and drinking.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Probióticos / Alcoolismo / Lacticaseibacillus rhamnosus / Doença Hepática Terminal / Hepatite Alcoólica Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Am J Gastroenterol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Probióticos / Alcoolismo / Lacticaseibacillus rhamnosus / Doença Hepática Terminal / Hepatite Alcoólica Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Am J Gastroenterol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos